Inhibition of IL‐6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|5|1035-1046

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.5, 2015-09, pp. : 1035-1046

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1227-1246

John Wiley & Sons Inc

Access to resources Recommend Favorite

The inhibition of Endostar on the angiogenesis and growth of gastrointestinal stromal tumor xenograft

By Wang Tian-bao  

Clinical and Experimental Medicine, Vol. 12, Iss. 2, 2012-06 ,pp. : 89-95

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of MK2 suppresses IL‐1β, IL‐6, and TNF‐α‐dependent colorectal cancer growth

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1702-1711

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor Size Significantly Correlates with Postoperative Liver Metastases and COX-2 Expression in Patients with Resectable Pancreatic Cancer

By  

Pancreatology, Vol. 7, Iss. 2-3, 2007-06 ,pp. : 167-173

Karger

Access to resources Recommend Favorite

Metformin decreases IL‐22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2556-2565

John Wiley & Sons Inc

Access to resources Recommend Favorite